CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Grant or award SVP, Chief Scientific Officer acquired 60,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Finance and Accounting sold 516 shares at $1.98 ($1,021)
- 4 Open-market sale CEO sold 7,121 shares at $1.88 ($13,391)
- 4 Open-market sale Chief Financial Officer sold 1,748 shares at $1.98 ($3,459)
- 4 Open-market sale General Counsel sold 2,037 shares at $1.98 ($4,031)
- 4 Open-market sale Chief Financial Officer sold 1,477 shares at $1.98 ($2,923)
- 4 Open-market sale EVP, Chief Development Officer sold 4,257 shares at $1.98 ($8,425)
- 4 Grant or award CEO acquired 105,000 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 40,000 shares (grant or award)
- 4 Grant or award General Counsel acquired 25,000 shares (grant or award)
- 4 Grant or award SVP, Finance and Accounting acquired 25,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, Chief Development Officer sold 7,463 shares at $1.42 ($10,612)
- 4 Open-market sale Chief Business Officer sold 4,206 shares at $1.42 ($5,982)
- 4 Open-market sale President and CEO sold 14,911 shares at $1.42 ($21,206)
- 4 Open-market sale General Counsel sold 5,602 shares at $1.42 ($7,968)
Page 6 of 20 · 400 filings